Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2021 and Recent Developments

Go back to Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2021 and Recent Developments

Avid Bioservices (CDMO) Reports Q4 Loss of $0.04/sh

June 29, 2021 4:11 PM EDT

Avid Bioservices (NASDAQ: CDMO) reported Q4 EPS of ($0.04), versus ($0.11) reported last year. Revenue for the quarter came in at $27.6 million versus the consensus estimate of $21.6 million.

GUIDANCE:

Avid Bioservices sees FY2021 revenue of $115-117 million, versus the consensus of $89.9... More